Stockreport

Bolt Biotherapeutics to Present at February Investor Conferences

Bolt Biotherapeutics, Inc.  (BOLT) 
PDF REDWOOD CITY, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immuno-oncolog [Read more]